The role of MRI in the conservative management of endometrial cancer

Gynecologic Oncology

Volumn 93, Issue 1, 2004, Pages 233-237

  Ben Shachar, Inbar ^a   Vitellas, Kenneth M ^b   Cohn, David E ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Endometrial cancer; MRI; Progestin

Indexed keywords

GESTAGEN; MEGESTROL;

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DIAGNOSTIC ACCURACY; ENDOMETRIUM CANCER; FEMALE; FEMALE FERTILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MEDICAL DECISION MAKING; MINIMAL RESIDUAL DISEASE; MYOMETRIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COUNSELING; PRIORITY JOURNAL; SURGICAL TECHNIQUE; UTERUS; UTERUS TUMOR;

ADULT; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MEGESTROL;

EID: 1842477779     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.01.031     Document Type: Article

References (34)

1. Silverberg S.G., Makowski E.L., Roche W.D. Endometrial carcinoma in women under 40 years of age: comparison of cases in oral contraceptive users and non-users. Cancer. 39:1977;592-598.
2. Crissman J.D., Azoury R.S., Barnes A.E., Schellhas H.F. Endometrial carcinoma in women 40 years of age or younger. Obstet. Gynecol. 57:1981;699-704.
3. Ostor A.G., Adam R., Gutteridge B.H., Fortune D.W. Endometrial carcinoma in young women. Aust. N. Z. J. Obstet. Gynaecol. 22:1982;38-42.
4. Gallup D.G., Stock R.J. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet. Gynecol. 64:1984;417-420.
5. Tran B.N., Connell P.P., Waggoner S., Rotmensch J., Mundt A.J. Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am. J. Clin. Oncol. 23:2000;476-480.
6. Geisler H.E., Huber C.P., Rogers S. Carcinoma of the endometrium in premenopausal women. Am. J. Obstet. Gynecol. 104:1969;657-663.
7. Tsoutsoplides G.C. Endometrial adenocarcinoma and the Stein-Leventhal syndrome. Am. J. Obstet. Gynecol. 147:1983;844-845.
8. Bokhman J.V., Chepick O.F., Volkova A.T., Vishnevsky A.S. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol. Oncol. 20:1985;139-155.
9. Kim Y.B., Holschneider C.H., Ghosh K., Nieberg R.K., Montz F.J. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer. 7:1997;320-327.
10. Randall T.C., Kurman R.J. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet. Gynecol. 90:1997;434-440.
11. Sardi J., Anchezar Henry J.P., Paniceres G., Gomez Rueda N., Vighi S. Primary hormonal treatment for early endometrial carcinoma. Eur. J. Gynaecol. Oncol. 19:1998;565-568.
12. Wang C.B., Wang C.J., Huang H.J., Hsueh S., Chou H.H., Soong Y.K.et al. Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer. 94:2002;2192-2198.
13. Kaku T., Yoshikawa H., Tsuda H., Sakamoto A., Fukunaga M., Kuwabara Y.et al. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett. 167:2001;39-48.
14. Sironi S., Colombo E., Villa G., Taccagni G., Belloni C., Garancini P.et al. Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology. 185:1992;207-212.
15. Yamashita Y., Harada M., Sawada T., Takahashi M., Miyazaki K., Okamura H. Normal uterus and FIGO stage I endometrial carcinoma: dynamic gadolinium-enhanced MR imaging. Radiology. 186:1993;495-501.
16. Scoutt L.M., McCarthy S.M., Flynn S.D., Lange R.C., Long F., Smith R.C. et al. Clinical stage I endometrial carcinoma: pitfalls in preoperative assessment with MR imaging. Work in progress. Radiology. 194:1995;567-572.
17. Cunha T.M., Felix A., Cabral I. Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and gross visual inspection. Int. J. Gynecol. Cancer. 11:2001;130-136.
18. Gordon A.N., Fleischer A.C., Dudley B.S., Drolshagan L.F., Kalemeris G.C., Partain C.L.et al. Preoperative assessment of myometrial invasion of endometrial adenocarcinoma by sonography (US) and magnetic resonance imaging (MRI). Gynecol. Oncol. 34:1989;175-179.
19. Belloni C., Vigano R., del Maschio A., Sironi S., Taccagni G.L., Vignali M. Magnetic resonance imaging in endometrial carcinoma staging. Gynecol. Oncol. 37:1990;172-177.
20. Hricak H., Rubinstein L.V., Gherman G.M., Karstaedt N. MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology. 179:1991;829-832.
21. Hricak H., Hamm B., Semelka R.C., Cann C.E., Nauert T., Secaf E.et al. Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging. Radiology. 181:1991;95-106.
22. Shibutani O., Joja I., Shiraiwa M., Asakawa T., Miyagi Y., Kudo T.et al. Endometrial carcinoma: efficacy of thin-section oblique axial MR images for evaluating cervical invasion. Abdom. Imaging. 24:1999;520-526.
23. Toki T., Oka K., Nakayama K., Oguchi O., Fujii S. A comparative study of pre-operative procedures to assess cervical invasion by endometrial carcinoma. Br. J. Obstet. Gynaecol. 105:1998;512-516.
24. Scheidler J., Hricak H., Yu K.K., Subak L., Segal M.R. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA. 278:1997;1096-1101.
25. Hricak H., Stern J.L., Fisher M.R., Shapeero L.G., Winkler M.L., Lacey C.G. Endometrial carcinoma staging by MR imaging. Radiology. 162:1987;297-305.
26. Ito K., Matsumoto T., Nakada T., Nakanishi T., Fujita N., Yamashita H. Assessing myometrial invasion by endometrial carcinoma with dynamic MRI. J. Comput. Assist. Tomogr. 18:1994;77-86.
27. Kinkel K., Kaji Y., Yu K.K., Segal M.R., Lu Y., Powell C.B.et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology. 212:1999;711-718.
28. Frei K.A., Kinkel K., Bonel H.M., Lu Y., Zaloudek C., Hricak H. Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging-a meta-analysis and Bayesian analysis. Radiology. 216:2000;444-449.
29. Kim S.H., Choi B.I., Han J.K., Kim H.D., Lee H.P., Kang S.B.et al. Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients. J. Comput. Assist. Tomogr. 17:1993;633-640.
30. Mamsen A., Ledertoug S., Horlyck A., Knudsen H.J., Rasmussen K.L., Nyland M.H.et al. The possible role of ultrasound in early cervical cancer. Gynecol. Oncol. 56:1995;187-190.
31. Munker R., Stengel A., Stabler A., Hiller E., Brehm G. Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's disease. Verification by laparotomy in 100 cases. Cancer. 76:1995;1460-1466.
32. Vinker S., Shani A., Open M., Fenig E., Dgani R. Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate? Eur. J. Obstet. Gynecol. Reprod. Biol. 83:1999;63-65.
33. Lien H.H., Blomlie V., Trope C., Kaern J., Abeler V.M. Cancer of the endometrium: value of MR imaging in determining depth of invasion into the myometrium. Am. J. Roentgenol. 157:1991;1221-1223.
34. Chen S.S., Rumancik W.M., Spiegel G. Magnetic resonance imaging in stage I endometrial carcinoma. Obstet. Gynecol. 75:1990;274-277.